Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Hofmaenner

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Ebiomedicine|February 16, 2024
Cholesterol in critical illness - a story evolving over a centuryDaniel A Hofmaenner
Critical Care (London, England)|May 12, 2023
From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDSDaniel A Hofmaenner, Sascha David
Intensive Care Medicine|March 18, 2022
Challenging management dogma where evidence is non-existent, weak or outdatedDaniel A Hofmaenner, Mervyn Singer
Intensive Care Medicine|June 17, 2022
The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's replyDaniel A Hofmaenner, Mervyn Singer
Intensive Care Medicine|September 25, 2024
Challenging management dogma where evidence is non-existent, weak, or outdated: part IIDaniel A Hofmaenner, Mervyn Singer
Journal of Clinical Monitoring and Computing|April 19, 2022
The impact of eye-tracking on patient safety in critical careDaniel A Hofmaenner, Philipp K Buehler
Burns : Journal of the International Society for Burn Injuries|August 17, 2021
Answer: How much surface can we debride with bromelain safely?Philipp K Buehler, Daniel A Hofmaenner
Critical Care (London, England)|August 18, 2021
Cholesterol and its association with muscle weakness in critical illnessDaniel A Hofmaenner, Anna Kleyman, Mervyn Singer
Seminars in Respiratory and Critical Care Medicine|July 5, 2024
Definition and Epidemiology of SepsisPietro Arina, Daniel A Hofmaenner, Mervyn Singer
Pediatric Research|April 28, 2023
Eye-tracking during newborn intubationsPhilipp K Buehler, Pedro David Wendel-Garcia, Daniel A Hofmaenner
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Ebiomedicine|February 16, 2024
Cholesterol in critical illness - a story evolving over a centuryDaniel A Hofmaenner
Critical Care (London, England)|May 12, 2023
From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDSDaniel A Hofmaenner, Sascha David
Intensive Care Medicine|March 18, 2022
Challenging management dogma where evidence is non-existent, weak or outdatedDaniel A Hofmaenner, Mervyn Singer
Intensive Care Medicine|June 17, 2022
The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's replyDaniel A Hofmaenner, Mervyn Singer
Intensive Care Medicine|September 25, 2024
Challenging management dogma where evidence is non-existent, weak, or outdated: part IIDaniel A Hofmaenner, Mervyn Singer
Journal of Clinical Monitoring and Computing|April 19, 2022
The impact of eye-tracking on patient safety in critical careDaniel A Hofmaenner, Philipp K Buehler
Burns : Journal of the International Society for Burn Injuries|August 17, 2021
Answer: How much surface can we debride with bromelain safely?Philipp K Buehler, Daniel A Hofmaenner
Critical Care (London, England)|August 18, 2021
Cholesterol and its association with muscle weakness in critical illnessDaniel A Hofmaenner, Anna Kleyman, Mervyn Singer
Seminars in Respiratory and Critical Care Medicine|July 5, 2024
Definition and Epidemiology of SepsisPietro Arina, Daniel A Hofmaenner, Mervyn Singer
Pediatric Research|April 28, 2023
Eye-tracking during newborn intubationsPhilipp K Buehler, Pedro David Wendel-Garcia, Daniel A Hofmaenner
Pageof 6